PREFER
Patient Preferences in benefit risk assessments during the drug life cycle
keywords: IMI projects Clinical trial design Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment
- Project website
- http://www.imi-prefer.eu/
- Start date
- 2016-10-01
- End date
- 2021-09-30
- Funding
- IMI2 - Call 5 (Grant number 115966)
- Types
- IMI projects
